Expert NetworkExpert InterviewMRK

Slingshot members are talking to an expert! The topic is:

Discussing the evolving landscape for HIV treatment, with a focus on Merck's single-tablet regimen of Doravirine/Islatravir

Executed on:Dec 8, 2025 10:00 AM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: University of Maryland
  • Associate Professor of Medicine in the Division of Infectious Diseases at the University of Maryland School of Medicine and attending physician at the University of Maryland Medical Center, specializing in HIV/AIDS and infectious diseases.
  • Serves as Director of the HIV Clinic and co-director of the Ryan White HIV Program, mentoring infectious disease fellows and leading multidisciplinary care teams for immunocompromised patients.
  • Leads research on HIV-associated complications, including opportunistic infections and antiviral resistance, with over 100 publications advancing treatment strategies for HIV in vulnerable populations.

Interview Goal

This call will discuss the current treatment landscape and the potential of Merck's single-tablet regimen of Doravirine/Islatravir for HIV-1 treatment including the recent Phase 3 data on Doravirine/Islatravir.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.